{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:19:38Z","timestamp":1772119178937,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06159-2","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T11:38:01Z","timestamp":1766489881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of [18F]-FDG-PET\/CT for lymph node staging in bladder cancer prior to radical cystectomy"],"prefix":"10.1007","volume":"44","author":[{"given":"Oscar","family":"Gouhizoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Pattou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Gu\u00e9na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderrahmane","family":"Khaddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Mebroukine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00eblle","family":"Margue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Gross-Goupil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Morgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Christophe","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Bladou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"2","key":"6159_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol f\u00e9vr 63(2):234\u2013241","journal-title":"Eur Urol f\u00e9vr"},{"issue":"6","key":"6159_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4111\/kju.2010.51.6.371","volume":"51","author":"JH Ku","year":"2010","unstructured":"Ku JH (2010) Role of pelvic lymphadenectomy in the treatment of bladder cancer: A mini review. Korean J Urol 1 Juin 51(6):371\u2013378","journal-title":"Korean J Urol 1 Juin"},{"key":"6159_CR3","doi-asserted-by":"crossref","unstructured":"Moussa M, Chakra MA, Saad W, Dellis A, Papatsoris A (2021) The role of 18F-FDG PET\/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer. Urol Oncol. d\u00e9c. ;39(12):833.e9-833.e17","DOI":"10.1016\/j.urolonc.2021.04.027"},{"issue":"4","key":"6159_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00345-018-2439-8","volume":"37","author":"J Crozier","year":"2019","unstructured":"Crozier J, Papa N, Perera M, Ngo B, Bolton D, Sengupta S et al (2019) Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis. World J Urol Avr 37(4):667\u2013690","journal-title":"World J Urol Avr"},{"key":"6159_CR5","doi-asserted-by":"crossref","unstructured":"Einerhand SMH, Zuur LG, Wondergem MJ, Boellaard TN, Barwari K, van Leeuwen PJ et al (2023) The Implementation of FDG PET\/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy? J Clin Med. 9 mai. ;12(10):3367","DOI":"10.3390\/jcm12103367"},{"issue":"5","key":"6159_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","volume":"87","author":"AG van der Heijden","year":"2025","unstructured":"van der Heijden AG, Bruins HM, Carrion A, Cathomas R, Comp\u00e9rat E, Dimitropoulos K et al (2025) European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines. Eur Urol 1 Mai 87(5):582\u2013600","journal-title":"Eur Urol 1 Mai"},{"key":"6159_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003981","author":"J Holzbeierlein","year":"2017","unstructured":"Holzbeierlein J, Bixler BR, Buckley DI, Chang SS, Holmes RS, James AC et al (2017) Amended 2020, 2024). https:\/\/www.auajournals.org\/doi\/https:\/\/doi.org\/10.1097\/JU.0000000000003981. J Urol [Internet]juill 2024 [cit\u00e9 12 mai 2025]; Disponible sur"},{"issue":"1","key":"6159_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000488200","volume":"95","author":"HK Ha","year":"2018","unstructured":"Ha HK, Koo PJ, Kim SJ (2018) Diagnostic accuracy of F-18FDG PET\/CT for preoperative lymph node staging in newly diagnosed bladder cancer patients: A systematic review and Meta-Analysis. Oncology 95(1):31\u201338","journal-title":"Oncology"},{"issue":"9","key":"6159_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00345-016-1772-z","volume":"34","author":"A Soubra","year":"2016","unstructured":"Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G et al (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol Sept 34(9):1229\u20131237","journal-title":"World J Urol Sept"},{"issue":"4","key":"6159_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/bju.16363","volume":"134","author":"M Longoni","year":"2024","unstructured":"Longoni M, Scilipoti P, Re C, Rosiello G, Nocera L, Pellegrino F et al (2024) Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET\/CT for lymph node assessment before radical cystectomy in bladder cancer patients. BJU Int Oct 134(4):636\u2013643","journal-title":"BJU Int Oct"},{"issue":"9","key":"6159_CR11","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.ejrad.2011.07.018","volume":"81","author":"YY Lu","year":"2012","unstructured":"Lu YY, Chen JH, Liang JA, Wang HY, Lin CC, Lin WY et al (2012) Clinical value of FDG PET or PET\/CT in urinary bladder cancer: A systemic review and meta-analysis. Eur J Radiol 1 Sept 81(9):2411\u20132416","journal-title":"Eur J Radiol 1 Sept"},{"issue":"3","key":"6159_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clgc.2022.01.009","volume":"20","author":"P Bertolaso","year":"2022","unstructured":"Bertolaso P, Brouste V, Cazeau AL, de Clermont-Gallerande H, Bladou F, Cabart M et al (2022) Impact of 18 FDG- PET CT in the management of muscle invasive bladder cancer. Clin Genitourin Cancer Juin 20(3):297\u2013297e6","journal-title":"Clin Genitourin Cancer Juin"},{"issue":"2","key":"6159_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/JU.0000000000001006","volume":"204","author":"S Dason","year":"2020","unstructured":"Dason S, Wong NC, Donahue TF, Meier A, Zheng J, Mannelli L et al (2020) Utility of routine preoperative 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET\/CT) in identifying pathologic lymph node metastases at radical cystectomy. J Urol ao\u00fbt 204(2):254\u2013259","journal-title":"J Urol ao\u00fbt"},{"issue":"3","key":"6159_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2021.01.005","volume":"5","author":"CS Voskuilen","year":"2022","unstructured":"Voskuilen CS, van Gennep EJ, Einerhand SMH, Vegt E, Donswijk ML, Bruining A et al (2022) Staging 18F-fluorodeoxyglucose positron emission tomography\/Computed tomography changes treatment recommendation in invasive bladder cancer. Eur Urol Oncol 1 Juin 5(3):366\u2013369","journal-title":"Eur Urol Oncol 1 Juin"},{"issue":"3","key":"6159_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000528524","volume":"107","author":"O Fitoussi","year":"2023","unstructured":"Fitoussi O, Roche JB, Riviere J, Wallerand H, Poulain JE, Gordien P et al (2023) Accuracy of FDG-PET\/CT for response evaluation of Muscle-Invasive bladder cancer following neoadjuvant or induction chemotherapy. Urol Int 107(3):239\u2013245","journal-title":"Urol Int"},{"issue":"9","key":"6159_CR16","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s11255-017-1637-4","volume":"49","author":"EEF van de Putte","year":"2017","unstructured":"van de Putte EEF, Vegt E, Mertens LS, Bruining A, Hendricksen K, van der Heijden MS et al (2017) FDG-PET\/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy. Int Urol Nephrol Sept 49(9):1585\u20131591","journal-title":"Int Urol Nephrol Sept"},{"issue":"9","key":"6159_CR17","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s003300050916","volume":"9","author":"JO Barentsz","year":"1999","unstructured":"Barentsz JO, Engelbrecht MR, Witjes JA, de la Rosette JJ, van der Graaf M (1999) MR imaging of the male pelvis. Eur Radiol 9(9):1722\u20131736","journal-title":"Eur Radiol"},{"issue":"3","key":"6159_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bju.14640","volume":"123","author":"M Assel","year":"2019","unstructured":"Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A et al (2019) Guidelines for reporting of statistics for clinical research in urology. BJU Int Mars 123(3):401\u2013410","journal-title":"BJU Int Mars"},{"issue":"1","key":"6159_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eururo.2020.04.048","volume":"78","author":"AJ Vickers","year":"2020","unstructured":"Vickers AJ, Assel MJ, Sjoberg DD, Qin R, Zhao Z, Koyama T et al (2020) Guidelines for reporting of figures and tables for clinical research in urology. Eur Urol Juill 78(1):97\u2013109","journal-title":"Eur Urol Juill"},{"issue":"1","key":"6159_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41824-023-00170-9","volume":"7","author":"V Pihl","year":"2023","unstructured":"Pihl V, Markus M, Abrahamsson J, Bl\u00e4ckberg M, Hagberg O, Kollberg P et al (2023) FDG-PET\/CT for lymph node staging prior to radical cystectomy. Eur J Hybrid Imaging 24 Juill 7(1):13","journal-title":"Eur J Hybrid Imaging 24 Juill"},{"issue":"5","key":"6159_CR21","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1007\/s13277-014-2361-7","volume":"36","author":"H Zhang","year":"2015","unstructured":"Zhang H, Xing W, Kang Q, Chen C, Wang L, Lu J (2015) Diagnostic value of [18F] FDG-PET and PET\/CT in urinary bladder cancer: a meta-analysis. Tumour Biol J Int Soc Oncodevelopmental Biol Med Mai 36(5):3209\u20133214","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med Mai"},{"key":"6159_CR22","doi-asserted-by":"publisher","first-page":"109168","DOI":"10.1016\/j.biopha.2019.109168","volume":"117","author":"WT Rahman","year":"2019","unstructured":"Rahman WT, Wale DJ, Viglianti BL, Townsend DM, Manganaro MS, Gross MD et al (2019) The impact of infection and inflammation in oncologic 18F-FDG PET\/CT imaging. Biomed Pharmacother Biomedecine Pharmacother Sept 117:109168","journal-title":"Biomed Pharmacother Biomedecine Pharmacother Sept"},{"issue":"2","key":"6159_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W et al (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging f\u00e9vr 42(2):328\u2013354","journal-title":"Eur J Nucl Med Mol Imaging f\u00e9vr"},{"issue":"1","key":"6159_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.euf.2017.06.005","volume":"5","author":"S Vind-Kezunovic","year":"2019","unstructured":"Vind-Kezunovic S, Bouchelouche K, Ipsen P, H\u00f8yer S, Bell C, Bjerggaard Jensen J (2019) Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and 18F-fluorodeoxyglucose positron emission Tomography\/Computed tomography: results from a High-volume centre including Long-term Follow-up. Eur Urol Focus Janv 5(1):90\u201396","journal-title":"Eur Urol Focus Janv"},{"issue":"4","key":"6159_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.semnuclmed.2021.12.004","volume":"52","author":"K Bouchelouche","year":"2022","unstructured":"Bouchelouche K (2022) PET\/CT in bladder cancer: an update. Semin Nucl Med 1 Juill 52(4):475\u2013485","journal-title":"Semin Nucl Med 1 Juill"},{"issue":"2","key":"6159_CR26","doi-asserted-by":"publisher","first-page":"e471912","DOI":"10.1200\/EDBK-25-471912","volume":"45","author":"J Bellmunt","year":"2025","unstructured":"Bellmunt J, Russell BM, Szabados B, Valderrama BP, Nadal R (2025) Current and future role of Circulating DNA in the diagnosis and management of urothelial carcinoma. Am Soc Clin Oncol Educ Book Janv 45(2):e471912","journal-title":"Am Soc Clin Oncol Educ Book Janv"},{"issue":"4","key":"6159_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11307-022-01715-3","volume":"24","author":"E Novruzov","year":"2022","unstructured":"Novruzov E, Dendl K, Ndlovu H, Choyke PL, Dabir M, Beu M et al (2022) Head-to-head Intra-individual comparison of [68Ga]-FAPI and [18F]-FDG PET\/CT in patients with bladder cancer. Mol Imaging Biol 24(4):651\u2013658","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"6159_CR28","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1097\/RLU.0000000000001432","volume":"42","author":"AB Rosenkrantz","year":"2017","unstructured":"Rosenkrantz AB, Friedman KP, Ponzo F, Raad RA, Jackson K, Huang WC et al (2017) Prospective pilot study to evaluate the incremental value of PET information in patients with bladder cancer undergoing 18F-FDG simultaneous PET\/MRI. Clin Nucl Med Janv 42(1):e8\u201315","journal-title":"Clin Nucl Med Janv"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06159-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06159-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06159-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T11:38:04Z","timestamp":1766489884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06159-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6159"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06159-2","relation":{"references":[{"id-type":"doi","id":"10.1097\/JU.0000000000003981","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8149121\/v1","asserted-by":"object"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol and data collection were approved by the local Ethics Committee (CER-BDX 2025-258). All patients received oral and written information and provided informed consent for retrospective data analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"59"}}